HEMISPHERX BIOPHARMA INC·4

Oct 19, 11:24 AM ET

STRAYER DAVID R 4

4 · HEMISPHERX BIOPHARMA INC · Filed Oct 19, 2018

Insider Transaction Report

Form 4
Period: 2018-10-17
Transactions
  • Award

    Options to buy Common Stock

    2018-10-17+123,106123,106 total
    Exercise: $0.22From: 2018-10-17Exp: 2028-10-17Common Stock (123,106 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT